PHILADELPHIA, April 4, 2018: Morgan Lewis represented global pharmaceutical compounding company Fagron in the purchase of Humco Holding Group, a diversified pharmaceutical company based in Austin, Texas (USA).
The transaction was for $47.5 million in cash with an earn-out of up to $22.5 million. All technologies, scientific data, patents and trademarks, as well as the production facility of Humco in Texas, are included in the purchase.
The Morgan Lewis team was led by partner Kevin Shmelzer and associate Doug Kingston. Partners Casey August, Michele Buenafe, Patrick Rehfield, Howard Young; and associates Jacqueline Berman, Samuel Bryant, Lauren Groebe, Benjamin Stango and Benjamin Weiss provided support.
For more details, read the announcement by Fagron.